X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-04-02 | EXAS | Baranick Brian | EVP, GM., Precision Oncology | S - Sale | $79.43 | -924 | 13,625 | -6% | -$73,393 | ||||||
| D | 2024-03-01 | EXAS | Baranick Brian | Gen. Mgr., Precision Oncology | S - Sale+OE | $59.32 | -2,323 | 14,549 | -14% | -$137,800 | |||||
| D | 2024-02-27 | EXAS | Baranick Brian | Gen. Mgr., Precision Oncology | S - Sale+OE | $56.89 | -2,027 | 12,148 | -14% | -$115,316 | |||||
2024-02-22 | EXAS | Baranick Brian | Gen. Mgr., Precision Oncology | S - Sale | $59.78 | -1,093 | 10,221 | -10% | -$65,340 | ||||||
| D | 2024-02-21 | EXAS | Baranick Brian | Gen. Mgr., Precision Oncology | S - Sale+OE | $61.50 | -895 | 9,280 | -9% | -$55,043 | |||||
2024-01-02 | EXAS | Baranick Brian | Gen. Mgr., Precision Oncology | S - Sale | $73.50 | -879 | 8,290 | -10% | -$64,607 | ||||||
| D | 2023-08-07 | EXAS | Baranick Brian | Gen. Mgr., Precision Oncology | S - Sale+OE | $85.04 | -1,350 | 9,169 | -13% | -$114,804 | |||||
| D | 2023-02-28 | EXAS | Baranick Brian | Gen. Mgr., Precision Oncology | S - Sale+OE | $61.12 | -1,932 | 7,668 | -20% | -$118,084 | |||||
| D | 2023-02-22 | EXAS | Baranick Brian | Gen. Mgr., Precision Oncology | S - Sale+OE | $62.72 | -838 | 5,646 | -13% | -$52,559 | |||||
| D | 2022-08-05 | EXAS | Baranick Brian | Gen. Mgr., Precision Oncology | S - Sale+OE | $47.12 | -984 | 4,755 | -17% | -$46,366 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |